Publications
5600 Results
- Journal / Conference
 - Clinical Cancer Research Jul 1;30(13):2709-2718
 - Year
 - 2024
 - Research Committee(s)
 - Breast
 - PMID
 - PMID38640040
 - PMC
 - PMC11287923
 - Study Number(s)
 - CTSU/E1Z11
 
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11
- Journal / Conference
 - Quality of Life Research Jul 30. doi: 10.1007/s11136-024-03746-5. Online ahead of print
 - Year
 - 2024
 - Research Committee(s)
 - Gastrointestinal
 - PMID
 - PMID39080091
 
Overall side effect assessment of oxaliplatin toxicity in rectal cancer patients in NRG oncology/NSABP R04
- Journal / Conference
 - Journal of the National Cancer Institute Apr 5;116(4):497-505
 - Year
 - 2024
 - Research Committee(s)
 - Cancer Care Delivery
 - PMID
 - PMID38175791
 
Interventions addressing health-related social needs among patients with cancer
- Journal / Conference
 - Contemporary Clinical Trials Jul:142:107564
 - Year
 - 2024
 - Research Committee(s)
 - Prevention, Screening, and and Surveillance
 - PMID
 - PMID38704119
 - PMC
 - PMC11180561
 - Study Number(s)
 - S1904
 
Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial
- Journal / Conference
 - Cancer Epidemiology, Biomarkers & Prevention Jun 13. doi: 10.1158/1055-9965.EPI-24-0096. Online ahead of print
 - Year
 - 2024
 - Research Committee(s)
 - Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
 - PMID
 - PMID38869494
 - Study Number(s)
 - S0000, SWOG-9217
 
Genome-wide analysis to assess if heavy alcohol consumption modifies the association between SNPs and pancreatic cancer risk
- Journal / Conference
 - Therapeutic Advances in Medical Oncology Apr 29:16:17588359241248336
 - Year
 - 2024
 - Research Committee(s)
 - Breast
 - PMID
 - PMID38686016
 - PMC
 - PMC11057345
 
TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy
- Journal / Conference
 - Oncologist Jun 3;29(6):e843-e847
 - Year
 - 2024
 - Research Committee(s)
 - Lung
 - PMID
 - PMID38597608
 - PMC
 - PMC11144964
 - Study Number(s)
 - LUNGMAP
 
A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master Protocol
- Journal / Conference
 - Lancet Oncology Aug;25(8):1038-1052
 - Year
 - 2024
 - Research Committee(s)
 - Genitourinary
 - PMID
 - PMID38942046
 - PMC
 - PMC11323681
 - Study Number(s)
 - CTSU/EA8143
 
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study
- Journal / Conference
 - Journal of Clinical Oncology Jul 1;42(19):2295-2305
 - Year
 - 2024
 - Research Committee(s)
 - Gastrointestinal
 - PMID
 - PMID38547438
 - Study Number(s)
 - CTSU/C80702
 
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials
- Journal / Conference
 - Studies in Health Technology and Informatics Aug 22:316:1368-1372
 - Year
 - 2024
 - Research Committee(s)
 - Multiple sites